
Olga V. Tcherkasskaya
Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 928 |
| Issued Applications | 461 |
| Pending Applications | 124 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16930755
[patent_doc_number] => 20210196644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => CANNABINOID COATED NANO-CAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/139846
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139846 | CANNABINOID COATED NANO-CAPSULES | Dec 30, 2020 | Pending |
Array
(
[id] => 18018823
[patent_doc_number] => 20220370322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/765211
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765211 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | Dec 29, 2020 | Abandoned |
Array
(
[id] => 18018823
[patent_doc_number] => 20220370322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/765211
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765211 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | Dec 29, 2020 | Abandoned |
Array
(
[id] => 18018823
[patent_doc_number] => 20220370322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/765211
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765211 | UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND | Dec 29, 2020 | Abandoned |
Array
(
[id] => 16776477
[patent_doc_number] => 20210113554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production
[patent_app_type] => utility
[patent_app_number] => 17/126811
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126811 | Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production | Dec 17, 2020 | Pending |
Array
(
[id] => 18978852
[patent_doc_number] => 11904006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Poly(diaminosulfide) particle-based vaccine
[patent_app_type] => utility
[patent_app_number] => 17/119384
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 49
[patent_no_of_words] => 18017
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119384 | Poly(diaminosulfide) particle-based vaccine | Dec 10, 2020 | Issued |
Array
(
[id] => 18368095
[patent_doc_number] => 11648242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Pharmaceutical composition comprising pimavanserin, process of preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/119250
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3550
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119250 | Pharmaceutical composition comprising pimavanserin, process of preparation and use thereof | Dec 10, 2020 | Issued |
Array
(
[id] => 18877358
[patent_doc_number] => 20240000727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => STABLE COATED SOLID PHARMACEUTICAL COMPOSITION OF AN OPIOID ANALGESIC AND AN ANTI-EPILEPTIC FOR PAIN
[patent_app_type] => utility
[patent_app_number] => 18/255244
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255244
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255244 | STABLE COATED SOLID PHARMACEUTICAL COMPOSITION OF AN OPIOID ANALGESIC AND AN ANTI-EPILEPTIC FOR PAIN | Dec 3, 2020 | Pending |
Array
(
[id] => 18107895
[patent_doc_number] => 20230000775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE
[patent_app_type] => utility
[patent_app_number] => 17/756720
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756720 | SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE | Nov 30, 2020 | Pending |
Array
(
[id] => 18107975
[patent_doc_number] => 20230000855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Substituted crotonamide pharmaceutical composition and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/780512
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780512 | Substituted crotonamide pharmaceutical composition and preparation method therefor | Nov 25, 2020 | Pending |
Array
(
[id] => 17625620
[patent_doc_number] => 20220160635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => LYOPHILIZED FORMULATIONS OF TEGAVIVINT
[patent_app_type] => utility
[patent_app_number] => 17/103468
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103468 | Lyophilized formulations of tegavivint | Nov 23, 2020 | Issued |
Array
(
[id] => 17312712
[patent_doc_number] => 20210401760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Composite Coating for an Active Agent
[patent_app_type] => utility
[patent_app_number] => 17/102036
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102036
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102036 | Composite coating for an active agent | Nov 22, 2020 | Issued |
Array
(
[id] => 18544160
[patent_doc_number] => 11717491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Solid nanoparticle with inorganic coating
[patent_app_type] => utility
[patent_app_number] => 17/096511
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 11492
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096511 | Solid nanoparticle with inorganic coating | Nov 11, 2020 | Issued |
Array
(
[id] => 16655867
[patent_doc_number] => 20210052503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME
[patent_app_type] => utility
[patent_app_number] => 17/089956
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089956 | Sustained release solid dosage forms for modulating the colonic microbiome | Nov 4, 2020 | Issued |
Array
(
[id] => 18064377
[patent_doc_number] => 20220395464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG
[patent_app_type] => utility
[patent_app_number] => 17/773339
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773339 | ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG | Oct 29, 2020 | Pending |
Array
(
[id] => 18064377
[patent_doc_number] => 20220395464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG
[patent_app_type] => utility
[patent_app_number] => 17/773339
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773339 | ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG | Oct 29, 2020 | Pending |
Array
(
[id] => 16924025
[patent_doc_number] => 11045481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Quetiapine oral liquid suspension and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/083497
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14724
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083497 | Quetiapine oral liquid suspension and use thereof | Oct 28, 2020 | Issued |
Array
(
[id] => 16791592
[patent_doc_number] => 20210121409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => CAPSULE FILLING COMPOSITION, METHOD OF PRODUCING CAPSULE FORMULATION WITH THE USE OF CAPSULE FILLING COMPOSITION, AND CAPSULE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/082042
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082042 | Capsule filling composition, method of producing capsule formulation with the use of capsule filling composition, and capsule formulation | Oct 27, 2020 | Issued |
Array
(
[id] => 16876819
[patent_doc_number] => 11026939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => High dosage valbenazine formulation and compositions, methods, and kits related thereto
[patent_app_type] => utility
[patent_app_number] => 17/074278
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 11607
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074278 | High dosage valbenazine formulation and compositions, methods, and kits related thereto | Oct 18, 2020 | Issued |
Array
(
[id] => 16612091
[patent_doc_number] => 20210030744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto
[patent_app_type] => utility
[patent_app_number] => 17/074383
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074383 | High dosage valbenazine formulation and compositions, methods, and kits related thereto | Oct 18, 2020 | Issued |